Middle East & Africa Hereditary Testing Market Size & Outlook
Middle East & Africa hereditary testing market, 2018-2030 (US$M)
Related Markets
MEA hereditary testing market highlights
- The MEA hereditary testing market generated a revenue of USD 276.8 million in 2023.
- The market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
- In terms of segment, hereditary non-cancer testing was the largest revenue generating disease type in 2023.
- Hereditary Cancer Testing is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 276.8 million |
| Market revenue in 2030 | USD 481.6 million |
| Growth rate | 8.2% (CAGR from 2023 to 2030) |
| Largest segment | Hereditary non-cancer testing |
| Fastest growing segment | Hereditary Cancer Testing |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hereditary Cancer Testing, Hereditary Non-cancer Testing |
| Key market players worldwide | Myriad Genetics Inc, Invitae Corp, Illumina Inc, Natera Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Quest Diagnostics Inc, CooperSurgical, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp, Sophia Genetics SA, Fulgent Genetics Inc, MedGenome, Centogene NV Ordinary Shares, The Cooper Companies Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.8% of the global hereditary testing market in 2023.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,021.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hereditary Testing Market Scope
Hereditary Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa hereditary testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary testing market will help companies and investors design strategic landscapes.
Hereditary non-cancer testing was the largest segment with a revenue share of 89.45% in 2023. Horizon Databook has segmented the Middle East & Africa hereditary testing market based on hereditary cancer testing, hereditary non-cancer testing covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing availability of several hereditary testing solutions through distributors and technology partners in MEA is expected to boost market growth. For instance, in February 2017, Premaitha Health appointed IgBioSystems to be an exclusive distributor for IONA tests in Saudi Arabia and UAE.
IgBioSystems, with its Dubai laboratory, acts as a regional hub for processing samples in NIPT. Similarly, Premaitha has appointed a distributor in Kuwait to expand the use of NIPTs in the region. In November 2017, Premaitha inaugurated four new laboratories in the Middle East to improve customer reach to its testing for Down's syndrome and other genetic conditions.
Reasons to subscribe to Middle East & Africa hereditary testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa hereditary testing market databook
-
Our clientele includes a mix of hereditary testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa hereditary testing market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa hereditary testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA hereditary testing market size, by country, 2018-2030 (US$M)
Middle East & Africa Hereditary Testing Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
